Stock Scorecard



Stock Summary for Clover Health Investments Corp - Class A (CLOV) - $2.56 as of 7/4/2025 12:47:18 AM EST

Total Score

11 out of 30

Safety Score

19 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for CLOV

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CLOV

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CLOV

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CLOV

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CLOV (19 out of 100)

Stock Price Rating (Max of 10) 3
Historical Stock Price Rating (Max of 10) 3
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for CLOV

Centene Pulls 2025 Guidance as Marketplace Growth Falters 7/2/2025 3:34:00 PM
Cigna Expands Coverage With RhinAer & Enhances Rhinitis Treatment 6/30/2025 6:29:00 PM
Clover Health Set to Join Russell 3000® Index - Clover Health Investments ( NASDAQ:CLOV ) 6/30/2025 12:30:00 PM
Here's Why MOH Shares Are Attracting Prudent Investors Now 6/20/2025 3:53:00 PM
Chamath Palihapitiya Asks If He Should Launch Another SPAC-70% Say No, Users Warn of Past Failures: 'No Crying In The Casino!' - Clover Health Investments ( NASDAQ:CLOV ) , Opendoor Technologies ( NASDAQ:OPEN ) 6/19/2025 10:06:00 AM
Ensign Enhances Presence With 3 New Acquisitions in 2 States 6/3/2025 3:44:00 PM
Here's Why You Should Hold Cigna Stock in Your Portfolio for Now 6/2/2025 4:22:00 PM
Here's Why You Should Add Pediatrix Medical to Your Portfolio Now 5/28/2025 1:40:00 PM
Here's Why Encompass Health Shares Are Attracting Investors Now 5/27/2025 3:17:00 PM
Are Medical Stocks Lagging Atossa Genetics ( ATOS ) This Year? 5/15/2025 1:40:00 PM

Financial Details for CLOV

Company Overview

Ticker CLOV
Company Name Clover Health Investments Corp - Class A
Country USA
Description Clover Health Investments, Corp. The company is headquartered in Franklin, Tennessee.
Sector Name FINANCE
Industry Name HOSPITAL & MEDICAL SERVICE PLANS
Most Recent Quarter 3/31/2025
Next Earnings Date 8/4/2025

Stock Price History

Last Day Price 2.56
Price 4 Years Ago 3.72
Last Day Price Updated 7/4/2025 12:47:18 AM EST
Last Day Volume 4,315,678
Average Daily Volume 8,580,956
52-Week High 4.87
52-Week Low 1.24
Last Price to 52 Week Low 106.45%

Valuation Measures

Trailing PE N/A
Industry PE 18.84
Sector PE 21.48
5-Year Average PE 3.37
Free Cash Flow Ratio 6.92
Industry Free Cash Flow Ratio 5.15
Sector Free Cash Flow Ratio 11.94
Current Ratio Most Recent Quarter 1.54
Total Cash Per Share 0.37
Book Value Per Share Most Recent Quarter 0.66
Price to Book Ratio 4.23
Industry Price to Book Ratio 2.46
Sector Price to Book Ratio 2.13
Price to Sales Ratio Twelve Trailing Months 0.94
Industry Price to Sales Ratio Twelve Trailing Months 0.38
Sector Price to Sales Ratio Twelve Trailing Months 3.31
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 416,542,000
Market Capitalization 1,066,347,520
Institutional Ownership 26.16%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 79.84%
Reported EPS 12 Trailing Months -0.04
Reported EPS Past Year 0.05
Reported EPS Prior Year -0.10
Net Income Twelve Trailing Months -25,113,000
Net Income Past Year -43,009,000
Net Income Prior Year -213,361,000
Quarterly Revenue Growth YOY 33.40%
5-Year Revenue Growth 24.29%
Operating Margin Twelve Trailing Months -0.28%

Balance Sheet

Total Cash Most Recent Quarter 155,439,000
Total Cash Past Year 194,543,000
Total Cash Prior Year 122,863,000
Net Cash Position Most Recent Quarter 135,439,000
Net Cash Position Past Year 174,543,000
Long Term Debt Past Year 20,000,000
Long Term Debt Prior Year 20,000,000
Total Debt Most Recent Quarter 20,000,000
Equity to Debt Ratio Past Year 0.94
Equity to Debt Ratio Most Recent Quarter 0.94
Total Stockholder Equity Past Year 341,143,000
Total Stockholder Equity Prior Year 286,394,000
Total Stockholder Equity Most Recent Quarter 336,075,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -8,679,000
Free Cash Flow Per Share Twelve Trailing Months -0.02
Free Cash Flow Past Year 33,289,000
Free Cash Flow Prior Year -116,455,000

Options

Put/Call Ratio 0.37
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.14
MACD Signal -0.13
20-Day Bollinger Lower Band 2.56
20-Day Bollinger Middle Band 3.40
20-Day Bollinger Upper Band 4.24
Beta 1.93
RSI 27.86
50-Day SMA 3.35
150-Day SMA 1.88
200-Day SMA 2.44

System

Modified 7/2/2025 8:49:42 PM EST